Welcome to the publications section.
We produce a range of publications, most of which are aimed at healthcare professionals or people working in the device or pharmaceutical industries. Some are available in full text as pdf documents.
16 Oct 2014 | EMA public consultation on functional specification for portal and database that will underpin the EU Clinical Trials Regulation (deadline 31 October 2014)
EMA have launched a public consultation on the functional specification for a portal and database that will underpin the EU Clinical Trials Regulation. Stakeholders are invited to review the document and provide comments to the EMA by 31 October 2014.
15 Oct 2014 | Class 4 Drug Alert (Caution in Use): Amoxil Vials for Injection 500mg and 1g, Augmentin Intravenous 600mg and 1.2g manufactured by Beecham Group PLC and Beecham Group Ltd trading as GlaxoSmithKline UK (EL (14)A/15)
GlaxoSmithKline has informed us of a very low incidence of cracks being found in vials used for packaging of these products.
13 Oct 2014 | Pantoprazole 20 mg and 40 mg Gastro-resistant Tablets - PL 17907/0484-0485 (404Kb)
13 Oct 2014 | Amitriptyline Hydrochloride 10mg/5ml Oral Solution - PL 29831/0460 (297Kb)
This section includes all our corporate publications, including our annual reports, corporate plans, business plans and our framework document.
This section includes the wide range of documents we produce which provide guidance on safety issues concerning medicines and medical devices.
This section includes the wide range of publications we produce to provide guidance to industry on the regulation of devices and medicines.
Public Assessment Reports (PARs)
Posters and leaflets